Clinical Trial Update: Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on toripalimab combined with donafenib for advanced hepatocellular carcinoma across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Donafenib (donafenib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Advanced Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN